Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-09 Sale |
2021-02-11 7:10 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
1,470 | $74.68 | $109,785 | 202,897 (Indirect Direct) |
View |
| 2020-10-08 Sale |
2020-10-13 6:45 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
52,906 | $40.74 | $2,155,603 | 342,132 (Indirect Direct) |
View |
| 2020-09-10 Sale |
2020-09-14 9:38 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
3,689 | $31 | $114,359 | 190,141 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-07 Exercise |
2021-02-11 7:10 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
4,250 | $0 | 202,897 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 6:54 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2020-10-08 Exercise |
2020-10-13 6:45 pm |
N/A 2026-07-01 |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
52,906 | $0 | 342,132 (Direct) |
View |
| 2020-10-08 Exercise |
2020-10-13 6:45 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
52,906 | $5.28 | 342,132 (Indirect) |
View |
| 2020-08-20 Exercise |
2020-08-24 8:38 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
5,643 | $0 | 158,320 (Direct) |
View |
| 2020-08-21 Tax Withholding |
2020-08-24 8:38 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
1,954 | $32.88 | 158,320 (Direct) |
View |
| 2020-08-18 Option Award |
2020-08-20 6:20 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 5:08 pm |
N/A 2030-06-04 |
NGM BIOPHARMACEUTICALS INC | NGM | Ho Carole Director |
39,515 | $0 | 39,515 (Direct) |
View |
Ownership |
2020-06-09 5:05 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | Ho Carole Director |
0 | $0 | 0 (Direct) |
View |